Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: R>G> who wrote (1813)	10/7/1998 5:05:00 PM
From: R>G>	Respond to of 4650

WASHINGTON, Oct 5 (Reuters) - A new Internet-based system that opened on Monday promises to make it easier for patients desperate to try the latest experimental cancer treatments, and their doctors, to find out about clinical trials. American Oncology Resources, Inc. says its AOR SecureNet will constantly scan patients' medical records to see if they meet the criteria for clinical trials. If there is a match, the system sends an e-mail to the doctor, nurse and the clinical research coordinator at the center where the patient is being treated. Clinical trials are the last step before a drug or treatment is approved by the Food and Drug Administration (FDA). They follow laboratory and animal trials and start out looking at whether a drug is safe to use in people, advancing to whether it works and if, so, who it works best in. The AOR website can be found at: aori.com